Klee Justin B.
Reporting owner on Forms 3, 4 and 5, CIK 1898314.
Klee Justin B. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-12.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AMLX · Amylyx Pharmaceuticals, Inc.CIK 1658551 | director, officer (Co-Chief Executive Officer) | 1 | 2026-11-12 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AMLX · Amylyx Pharmaceuticals, Inc.Common Stock | 2026-11-09 | S sold | -37,483 | $29.3917 | 3,575,573 | Form 4 |
| AMLX · Amylyx Pharmaceuticals, Inc.Common Stock | 2026-11-09 | S sold | -62,517 | $30.1062 | 3,513,056 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-458246 | Amylyx Pharmaceuticals, Inc. | 2026-11-12 |